Background
Vitamin D is either obtained from diet or synthesised in the skin from 7-dehydrocholesterol. In the liver the vitamin undergoes hydroxylation into 25(OH)D, the major circulating form of the vitamin. Another hydroxylation at 1-α-carbon takes place in the renal tubules to form 1, 25-dihydroxy-D (calcitriol), the biologically active form. Calcitriol maintains the plasma calcium and phosphorus levels by increasing the expression of the epithelial calcium channel-TRPV6 and the intracellular calcium transporterCalbindin 9 K. 1, 2 In the presence of calcitriol, the efficiency of intestinal calcium and phosphorus absorption increases to 40 per cent and 80 per cent, respectively. 3 Moreover, the 25(OH)D and calcitriol are known to stimulate the secretion and action of insulin, 4 inhibit renin angiotensin aldosterone system, 5 and alter the inflammatory response associated with atherosclerosis. 6 Thus low serum levels of vitamin D are known to be associated with hypertension, insulin resistance, 3 inflammation, and progression of chronic kidney disease (CKD). [7] [8] [9] Despite the routine dietary supplementation, vitamin D deficiency is common in elderly individuals, people with limited sun exposure, and those with fat malabsorption. 10 It was reported that 70-80 per cent of patients with CKD stages 3 and 4 were vitamin D deficient and 26 per cent of these patients were severely deficient. 11 The parathyroid hormone (PTH), an 84-amino acid polypeptide hormone, is also involved in the regulation of plasma calcium and phosphate levels. The drop in serum ionised calcium levels is known to trigger the synthesis and release of PTH. In patients with advanced renal disease, the synthesis of calcitriol is depressed leading to reduction in the serum-ionised calcium levels with elevated serum phosphate concentration due to reduced clearance. Both phenomena may lead to the development of secondary hyperparathyroidism. The resultant increased PTH production is believed to be the predominant cause of renal osteodystrophy and the common treatment to control the secondary hyperparathyroidism is vitamin D therapy, which ameliorates renal osteodystrophy 12, 13 and improves patient survival. 14, 15 The lifestyle of the Saudi population has changed dramatically in the past few decades causing a more sedentary type of life. This has caused an increase in the prevalence of several metabolic disorders such as obesity, type 2 diabetes mellitus, cardiovascular diseases, and more recently vitamin D deficiency.
Hail district lies in the mid-north of Saudi Arabia at a higher altitude and with sunshine throughout the year. No study has been carried out in this region to investigate the vitamin D status and PTH levels in kidney disease patients. Therefore, in the present study we aimed to investigate the influence of renal impairment on vitamin D status and the associated changes in serum PTH in a group of patients from Hail region. We also examined the possible co-existence of other factors that may affect the serum vitamin D and PTH levels in these patients.
Method
Sample Following the release of results, a copy of the data was entered in our records and the residual serum samples were stored at -20°C for the assay of vitamin D and PTH using commercial kits.
The estimated glomerular filtration rate (eGFR) for each patient was then calculated according to the CKD Epidemiology Collaboration Equation. 16 The patients were then classified into stage 1 (with eGFR≥90), stage 2 with eGFR 89-60, stage 3 with eGFR 59-30, and stage 4 with eGFR≤29. Unfortunately, only two patients had eGFR<15 ml/min/1.73m 2 (stage 5), therefore, they were excluded and the study was confined to the stages 1 to 4.
Biochemical analysis
The measurements of serum creatinine, blood urea nitrogen (BUN), uric acid, calcium, and phosphate were carried out using The Dimension (RxL XPAD-Germany). Serum intact PTH (1-84) and vitamin D (25-(OH)D) were estimated by Autoanalyser (ELecsys 2010, Cobas E 411-Mannheim Germany).
Statistical analysis
Results are expressed as means ± SD. The differences between the means were computed by one-way ANOVA using Statistical Package for Social Sciences version 16.0 (SPSS Inc, Chicago, IL, USA). The significance of differences between the means was carried out by Unpaired Student`s T-test. P values <0.05 were considered significant. The regression analysis between the various parameters was carried out by Spearman`s Regression analysis. P values <0.05 were considered significant.
Results
From the total number of patients who visited the Kidney Unit during the study period (n=167), 71 patients (M=27 and F=44) were excluded, and 96 patients files (M=42, F=54) were selected. The patients had an average age (39.09 ± 14 yrs), range (14-85 yrs). As shown in Table 1 , on the basis of the eGFR, the patients were classified into CKD stages 1-4. The mean age increased progressively from stage 1 (32.19 ± 9.74 yrs) to stage 4 (45.60 ± 19.46 yrs). In the stage 4 patients, the ratio of female to male was 5:1 compared to stage 1 (ratio 1:1). As expected, the concentrations of serum creatinine, BUN, and uric acid concentrations increased progressively from stage 1 to stage 4. On the other hand, there was a slight but significant (p<0.05) increase in the serum total calcium concentration by 8.17 per cent in the stage 4 patients, whereas the serum phosphate increased by 15.74 per cent in stage 4 patients compared to the stage 1 group. The vitamin D status was classified according to Lavie et al. 17 as
: (SD: severely deficient, D: deficient, MD: mildly deficient and S: sufficient).
On the other hand, the kidney function exhibited that 33.33 per cent of patients with abnormally elevated serum creatinine level had severe vitamin deficiency, whereas, only 13.33 per cent of them had vitamin sufficiency.
Discussion
The well-established functions of vitamin D and PTH are associated with the bone health, but several epidemiological studies have shown that vitamin D deficiency is also associated with increased risk of many non-skeletal diseases such as cancer, autoimmune, and cardiovascular diseases. 18, 19 In the present study we investigated the possible important factors which may predispose subjects to vitamin D deficiency. Female subjects were more vulnerable to vitamin D deficiency than male subjects, which is understandable considering sunlight is the most important source of vitamin D, but for religious reasons Saudi females have their bodies entirely covered in black whenever they leave home. This is likely a main factor contributing to widespread vitamin deficiency among the Saudi female population. Similar findings were also reported where Saudi females in other regions of the country had low serum vitamin D levels compared to their counterparts in other countries. 20 Furthermore, obesity is also more prevalent among the Saudi female population than the male population 21 and it is known that more body fat hinders the absorption of UV light by the skin, which may in turn impair the vitamin synthesis by the body. 22 Also, more vitamin D is known to be sequestered in the excess adipose tissue. 23 The second important factor observed in this study is age, where older subjects were more likely to be vitamin D deficient. This factor corresponded with some studies where the elderly population had reduced serum vitamin D levels compared to younger people. It has been suggested that the elderly have lower capacity for UVB-induced vitamin D synthesis in the skin, thus making them more susceptible to vitamin deficiency. 24, 25 Moreover, younger subjects are healthier and are more likely to be exposed to sunlight.
Kidney function was the third factor that demonstrated a strong influence on the vitamin homeostasis. Our data shows 66 per cent of the patients with impaired kidney function had mild to severe vitamin D deficiency. The association of kidney disease with vitamin D deficiency emerges from the fact that healthy kidneys play an important role in metabolising vitamin D. It was reported that on average, only about one-quarter of stages 3 and 4 CKD patients seem to have sufficient vitamin D levels of more than 30 ng/ml. 26 The mechanism underlying this phenomenon is believed to be multifactorial:
1. Patients with CKD have limited exposure to sunlight due to their inability to participate in outdoor physical activity. 2. Patients with CKD are known to be unable to produce vitamin D3 in the skin even though the concentration of 7-dehydrocholesterol in their epidermis is similar to their age-matched controls. 27 3. The proteinuria in these patients leads to urinary waste of vitamin D-binding protein and the vitamin D metabolites. 28 Since the activation of 25-OH-D into calcitriol takes place mainly in the kidney, the calcitriol deficiency occurs with progression in kidney disease. The mechanism underlying the calcitriol deficiency in the CKD patients is that the activity of 1-α hydroxylase, the renal enzyme responsible for calcitriol synthesis, is suppressed by uraemia and acidosis, and also due to the reduced availability of its substrate-25 (OH)D. 29 Moreover, in these patients there is increased production of the fibroblast growth factor (FGF)-23 that down regulates the expression of renal 1-α hydroxylase enzyme. [30] [31] [32] Our data indicated significant secondary hyperparathyroidism in patients with stage 4 of the disease, with a significant correlation between the log PTH and serum creatinine (r=0.704, p<0.0001). In normal subjects, the secretion of PTH is maintained by the presence of FGF-23, 33 whereas in hypocalcaemia caused by the calcitriol deficiency, the expression of Klotho is increased in parathyroid gland and kidneys. 34 The expressed Klotho plays a role in extracellular calcium regulation and release of PTHcausing hyperparathyroidism. Klotho raises the serum calcium by stimulating tubular calcium reabsorption through glycosylation and anchoring of the calciumtransporting channel. 35 This explains the severe hyperparathyroidism in stage 4 patients. Although the exposure of parathyroid glands to FGF23 is believed to inhibit PTH secretion, patients with CKD were shown to develop secondary hyperparathyroidism despite the high levels of serum FGF23, indicating development of a parathyroid-FGF23 resistance. 36 The secondary hyperparathyroidism that ensues in CKD can lead to disturbance in mineral metabolism and highturnover bone disease. Our results indicated a strong correlation between PTH and the vitamin status. It showed that 42.8 per cent and 35.7 per cent of the subjects with high serum PTH levels had vitamin D deficiency and severe deficiency, respectively. This association between PTH and vitamin D level was supported by the significant negative correlation (r=-0.407, p=0.0006). Several investigators have also reported the correlation between the induced secondary hyperparathyroidism and vitamin D deficiency in CKD. The calcitriol is known as a potent negative regulator of PTH production. It binds the vitamin D-receptor complex on the parathyroid cells and down regulates PTH gene expression. 37 Thus, with progression of kidney disease the diminished calcitriol production reverses the suppressed PTH gene expression leading to the hyperparathyroidism. 29 Our results showed significant increases in serum phosphate levels in stage 3 and stage 4 patients. This was in congruence with several reports that showed overt hyperphosphataemia in patients with CKD when the GFR falls below 40 mL/min/1.73m 2 caused by inability of the kidneys to excrete phosphate. 38, 39 However, the serum phosphate homeostasis in CKD is a balance between the phosphate retention by the kidney and the stimulatory effect of PTH for phosphate excretion. Moreover, the elevated FGF-23 level is known to decrease the expression of a sodium-phosphate co-transporter in the proximal tubule, a protein responsible for phosphate reabsorption, and thus enhances the excretion of phosphate in urine. 40 Interestingly, our data also showed a slight but significant increase in the serum calcium concentrations of the stage 3 and stage 4 patients. This was in contrast to the findings of other authors who reported consistent depression in the serum calcium levels. 36 The mechanism underlying the serum calcium homeostasis in CKD is rather complex. Although, vitamin D deficiency is believed to reduce the intestinal calcium absorption by about 50 per cent, the reduction in serum calcium triggers the release of PTH, which is believed to correct the serum calcium by promoting mobilisation of calcium from bone and increasing its reabsorption from the renal tubules. 41, 42 High dietary calcium content is believed to influence the plasma calcium concentration. This is also true in patients treated by calcium based-phosphate binders that showed positive calcium balance. 36, 43, 44 In a study involving Saudi haemodialysis patients receiving sevelamer carbonate, it was shown that 52 per cent of the patients developed serum calcium levels greater than 2.75mmol/L. 45 Spiegel and Brady 46 reported that subjects with advanced stage 3 or stage 4 CKD were in slightly negative calcium balance on 800mg calcium intake, but became in marked positive balance when they ingested 2000mg of elemental calcium. The calcium load in these patients was even higher than the normal controls.
Hail's population is mostly Bedouins raising camels and consuming significant amounts of camel milk. Studies have shown camel milk to be very rich in calcium, containing about 0.84g/L. 47 In a study comparing camel milk with the human milk, it was shown that camel milk contains about three-fold the calcium content of human milk (109mg/100ml of camel milk compared to 34mg/100ml of human milk). 48 This indicates that an individual consuming 2.0 to 2.5 litres of camel milk per day will be close to the target of 2000mg calcium. Thus, the amount of dietary calcium consumed by the Hail CKD patients from the camel milk may in part underlay this elevated serum calcium levels.
The present study has investigated, for the first time, the vitamin D status and the secondary hyperparathyroidism in kidney disease patients of Hail region. It has also highlighted the social factors that may influence the vitamin status. The author suggests a wide-scale population study to determine the prevalence of vitamin deficiency among the elderly and females. A limitation of the study is the relatively small sample size and not involving the stage 5 (with eGFR <15 ml/min/1.57m
2 ) patients. A wider study involving the endstage kidney disease patients on haemodialysis is now underway, and it may consider more of the unanswered questions.
Conclusion
The present results demonstrate vitamin D deficiency and secondary hyperparathyroidism in stage 4 CKD patients from Hail region in Saudi Arabia. In these patients, the vitamin D deficiency was prominent in females and older ages. There was a slight increase in serum calcium and significant increase in the serum phosphate concentrations. These findings are useful for providing data that may assist with management of CKD patients.
